407006005: Product containing efalizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing efalizumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing efalizumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

2150836017 Efalizumab (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2158640011 Efalizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3522560012 Product containing efalizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3522561011 Product containing efalizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3667049015 Efalizumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3714600019 Efalizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107824301000001110 Efalizumab en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing efalizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing efalizumab	Has active ingredient	Efalizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing efalizumab	Has active ingredient	Immunosuppressant	false	Inferred relationship	Existential restriction modifier
Product containing efalizumab	Is a	Product containing immunomodulator	true	Inferred relationship	Existential restriction modifier
Product containing efalizumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Raptiva	Is a	False	Product containing efalizumab	Inferred relationship	Existential restriction modifier
Efalizumab 125mg/vial lyophilized powder for injection	Is a	False	Product containing efalizumab	Inferred relationship	Existential restriction modifier
Efalizumab	Is a	True	Product containing efalizumab	Inferred relationship	Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials	Is a	False	Product containing efalizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets